← back to search

Ines Nevelsteen

Universitair Ziekenhuis Leuven · BE
Area of research
Cancer Research · Oncology
Research interest
Research interests include Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers, Advanced Breast Cancer Therapies, and Cancer Cells and Metastasis.
h-index
21
citations
2,340
works
214
NIH funding
primary concept
Medicine
email

Recent publications

Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program
npj Breast Cancer 2024cited by 17position: middledoi
Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer
European Journal of Cancer 2023cited by 58position: middledoi
Obesity-associated changes in molecular biology of primary breast cancer
Nature Communications 2023cited by 55position: middledoi
Pregnancy After Breast Cancer in Young <i>BRCA </i>Carriers
JAMA 2023cited by 53position: middledoi
Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast
Nature Communications 2022cited by 156position: middledoi
Manual lymphatic drainage with or without fluoroscopy guidance did not substantially improve the effect of decongestive lymphatic therapy in people with breast cancer-related lymphoedema (EFforT-BCRL trial): a multicentre randomised trial
Journal of physiotherapy 2022cited by 43position: middledoi
Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer
Scientific Reports 2022cited by 40position: middledoi
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~200,000 patients
Research Square 2022cited by 2position: middledoi
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
Nature Medicine 2021cited by 895position: middledoi
Behavior of metastatic breast cancer according to subtype
Breast Cancer Research and Treatment 2020cited by 47position: middledoi
What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review
Supportive Care in Cancer 2019cited by 83position: middledoi
What is the best method to determine excessive arm volume in patients with breast cancer–related lymphoedema in clinical practice? Reliability, time efficiency and clinical feasibility of five different methods
Clinical Rehabilitation 2019cited by 43position: middledoi
Diabetes mellitus and the metabolic syndrome do not abolish, but might reduce, the cardioprotective effect of ischemic postconditioning
Journal of Thoracic and Cardiovascular Surgery 2013cited by 37position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kevin Punie · Ziekenhuisnetwerk Antwerpen Stuivenberg4 papers (2020–2023)Hans Wildiers · CHU Dinant Godinne UCL Namur4 papers (2020–2023)Giuseppe Floris · Twitter (United States)4 papers (2020–2023)Ann Smeets · Universitair Ziekenhuis Leuven4 papers (2020–2023)Patrick Neven · European Organisation for Research and Treatment of Cancer4 papers (2020–2023)An De Groef · KU Leuven3 papers (2019–2022)Christine Desmedt · KU Leuven3 papers (2021–2023)Wiebren Tjalma · University of Antwerp3 papers (2019–2022)Nele Devoogdt · KU Leuven3 papers (2019–2022)Nick Gebruers · University of Antwerp3 papers (2019–2022)Tessa De Vrieze · KU Leuven3 papers (2019–2022)Sarah Thomis · KU Leuven3 papers (2019–2022) · 2 papers (2019–2022) · 2 papers (2019–2022)Margot Van Mechelen · KU Leuven1 papers (2020–2020)Junbin Qian · Wenzhou Medical University1 papers (2021–2021)M. Hanssens · KU Leuven1 papers (2022–2022)Vincent Geldhof · AZ Klina1 papers (2013–2013)Tom Dresselaers · KU Leuven1 papers (2013–2013)Laurien Van Dyck · KU Leuven1 papers (2021–2021)